Inhibiting glutaminase (GLS) activity by siRNA or the small molecule inhibitor bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) slowed the growth of GBM cells expressing IDH1-mut [61]. The gene discussed is IDH1; the disease is glioblastoma.